Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Patient dies in Neurogene's Rett syndrome study
6 months ago
R&D
Cell/Gene Tx
With yearslong reorganization behind it, Novartis increases its sales guidance
6 months ago
Pharma
FDA adcomm raises risk questions on AstraZeneca’s Andexxa
6 months ago
FDA+
AstraZeneca culls Phase 2 opioid use disorder drug
6 months ago
R&D
Jazz wins approval for bispecific in biliary tract cancer
6 months ago
Pharma
FDA+
At Jefferies, all that manufacturers want to talk about is GLP-1s
6 months ago
Manufacturing
RFK Jr. and Elon Musk want to ban pharma ads. They wouldn't be the first to try
6 months ago
Pharma
Marketing
Samsung Bio's new $668M client; Sanofi expands a factory in France
6 months ago
Manufacturing
Cidara's $100M PIPE; Pyxis Oncology's stock falls on Phase 1 data
6 months ago
News Briefing
FDA vaccine chief Peter Marks pledges to stay as long as he's welcome
6 months ago
Pharma
Caltech spinout debuts with AI-driven 'mirror peptide' platform
6 months ago
R&D
Novartis seeks more bolt-on deals as it purchases neuro startup for up to $1.1B
6 months ago
Deals
R&D
Amgen names Stanford geneticist and biotech founder to CSO post
6 months ago
People
Pharma
Kyowa Kirin acquires ex-US rights to Kura’s leukemia treatment for $330M upfront
6 months ago
Deals
NewAmsterdam aces Phase 3 trial, but investors are skeptical
6 months ago
R&D
Pharma
Venrock adds $500M to healthcare investing strategy after outlining 10th fund in January
6 months ago
Financing
Startups
FDA updates label of 33-year-old cancer drug with new dose and warning
6 months ago
Pharma
FDA+
When generative AI meets the FDA: First digital health adcomm kicks off discussion
6 months ago
AI
FDA+
Novo and Viking present new MASH data, but analysts remain confident in Madrigal's Rezdiffra
6 months ago
R&D
23andMe inks new research partnership as it winds down internal drug development efforts
6 months ago
Deals
Health Tech
Updated: Sage reports Phase 2 failure in Huntington's disease, ends drug's development
6 months ago
R&D
Pfizer taps oncology head Boshoff as Dolsten's chief scientific officer successor
6 months ago
People
Pharma
Carolyn Bertozzi’s latest biotech debuts with $30M seed round and a sugary spin on immunotherapy
6 months ago
Financing
Startups
Exclusive: Former Pfizer commercial chief Angela Hwang to join Flagship
6 months ago
People
Startups
First page
Previous page
73
74
75
76
77
78
79
Next page
Last page